This is a preview of subscription content, log in via an institution to check access.
Notes
The study was funded by Amgen (Europe) GmbH.
European Society of Cardiology/European Atherosclerosis Society
Reference
Sciattella P, et al. Healthcare Resource Utilization, Cardiovascular Event Rate and Use of Lipid-Lowering Therapies in Secondary Prevention of ASCVD in Hospitalized Patients in Italy. Advances in Therapy : 31 Oct 2021. Available from: URL: http://doi.org/10.1007/s12325-021-01960-y
Rights and permissions
About this article
Cite this article
Suboptimal lipid-lowering therapy in secondary prevention of atherosclerotic CVD incurs high cost in Italy. PharmacoEcon Outcomes News 891, 26 (2021). https://doi.org/10.1007/s40274-021-08184-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-08184-7